Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
10/15/20242:00AMGlobeNewswire Inc.Caledonia Mining Corporation Plc: Third Quarter Production at Blanket MineAMEX:CMCLCaledonia Mining Corporation Plc
10/15/20242:00AMGlobeNewswire Inc.Dianomic and Boon Logic Partner to Deliver Advanced Anomaly Detection for Industrial Data Pipelines and IIoT
10/15/20242:00AMGlobeNewswire Inc.Caledonia Mining Corporation Plc: Third Quarter Production at Blanket MineCMCL.LN
10/15/20242:00AMGlobeNewswire Inc.Former UK Prime Minister David Cameron Joins Oxford-Harrington Rare Disease Centre (OHC) as Chair of its Advisory Council
10/15/20242:00AMGlobeNewswire Inc.Caledonia Mining Corporation Plc: Third Quarter Production at Blanket MineCMCL.L
10/15/20242:00AMGlobeNewswire Inc.ING completes share buyback programmeEU:INGAING Groep NV
10/15/20242:00AMBusiness WireRegenerative Agriculture Pioneer, Advancing Eco Agriculture, Announces Global Partnership with Turkish Precision Ag Technology Company, Topraq, to Significantly Expand Access to Regenerative Solutions
10/15/20242:00AMBusiness WireADOCIA Announces Patenting Stable Combinations of GLP-1 and Amylin Analogs for the Treatment of Obesity and Diabetes Using Its BioChaperone® PlatformEU:ADOCAdocia
10/15/20242:00AMBusiness WireLazard Welcomes Will Thompson as Managing Director, Healthcare ServicesNYSE:LAZLazard Inc
10/15/20242:00AMBusiness WirePolicyholder Expectations Pose Challenges for Life Insurers at Every Stage of the Customer Journey
10/15/20242:00AMBusiness WireOPM annonce la présentation d’un poster sur OPM-101, inhibiteur de la kinase RIPK2, chez les volontaires sains lors du congrès de l’UEG Week 2024EU:ALOPMOncodesign Precision Medicine SA
10/15/20242:00AMBusiness WireADOCIA annonce breveter des combinaisons stables d’analogues de GLP-1 et d’amyline pour le traitement de l’obésité et du diabète grâce à sa plateforme BioChaperone®EU:ADOCAdocia
10/15/20242:00AMBusiness WireOPM Announces Poster Presentation on OPM-101, a RIPK2 Kinase Inhibitor, in Healthy Volunteers at UEG Week 2024 ConferenceEU:ALOPMOncodesign Precision Medicine SA
10/15/20241:58AMAlliance NewsAlliance NewsLONDON MARKET EARLY CALL: Stocks seen up ahead of European rate call
10/15/20241:57AMAlliance NewsAlliance NewsUK government announces GBP68 million for homes on brownfield land
10/15/20241:56AMAlliance NewsAlliance NewsJapan industrial production ends summer with return to declines
10/15/20241:54AMAlliance NewsAlliance NewsGlobal public debt expected to exceed USD100 trillion this year — IMF
10/15/20241:52AMPR Newswire (US)DBN Group Invites Global Agricultural Biotech Companies to Co-create a Leading Innovation Ecosystem at DBN Phoenix International Innovation Park
10/15/20241:51AMBusiness WireCAI presenta la nuova audace identità del marchio in occasione dell'ISPE Annual Meeting & Expo
10/15/20241:50AMAlliance NewsAlliance NewsInvestments from private sector to support UK government housing drive
10/15/20241:45AMAlliance NewsAlliance NewsTaiwan detects record 153 Chinese military aircraft after drills
10/15/20241:43AMAlliance NewsAlliance NewsSecurity Council voices concern over Israel attacks on UN peacekeepers
10/15/20241:41AMPR Newswire (US)World's first biodegradable plastic produced from CO2 emissions in Finland
10/15/20241:38AMAlliance NewsAlliance NewsHarris slams Trump over military threat to "enemy from within"
10/15/20241:37AMPR Newswire (US)Global Times: Ru Kiln heritage revitalized for modern life
10/15/20241:36AMAlliance NewsAlliance NewsKamala Harris agrees to interview with conservative Fox News
10/15/20241:30AMAlliance NewsAlliance NewsGET READY: Bellway, Bytes Technology, Qinetiq, Reach, Wise at 0700 BST
10/15/20241:30AMAlliance NewsAlliance NewsAlliance News UK - start of day
10/15/20241:30AMBusiness WireMaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host DiseaseEU:MAATMaat Pharma SA
10/15/20241:30AMGlobeNewswire Inc.ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) TechnologyLSE:ONWDOnward Opportunities Limited

Your Recent History

Delayed Upgrade Clock